Sweden · Delayed Price · Currency is SEK Xvivo Perfusion AB Statistics
Total Valuation
STO:XVIVO has a market cap or net worth of SEK 6.28 billion. The enterprise value is 6.09 billion.
| Market Cap | 6.28B |
| Enterprise Value | 6.09B |
Important Dates
The last earnings date was Thursday, October 22, 2026.
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:XVIVO has 31.50 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 31.50M |
| Shares Outstanding | 31.50M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.25% |
| Owned by Institutions (%) | 27.29% |
| Float | 25.13M |
Valuation Ratios
The trailing PE ratio is 48.73 and the forward PE ratio is 40.91.
| PE Ratio | 48.73 |
| Forward PE | 40.91 |
| PS Ratio | 6.70 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 4.06 |
| P/FCF Ratio | 36.67 |
| P/OCF Ratio | 23.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.61, with an EV/FCF ratio of 35.57.
| EV / Earnings | 48.33 |
| EV / Sales | 6.50 |
| EV / EBITDA | 32.61 |
| EV / EBIT | 48.74 |
| EV / FCF | 35.57 |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.91 |
| Quick Ratio | 2.69 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | 0.69 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 5.91% and return on invested capital (ROIC) is 5.17%.
| Return on Equity (ROE) | 5.91% |
| Return on Assets (ROA) | 3.22% |
| Return on Invested Capital (ROIC) | 5.17% |
| Return on Capital Employed (ROCE) | 5.32% |
| Weighted Average Cost of Capital (WACC) | 12.11% |
| Revenue Per Employee | 4.63M |
| Profits Per Employee | 622,454 |
| Employee Count | 207 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.08 |
Taxes
In the past 12 months, STO:XVIVO has paid 26.75 million in taxes.
| Income Tax | 26.75M |
| Effective Tax Rate | 17.19% |
Stock Price Statistics
The stock price has increased by +10.14% in the last 52 weeks. The beta is 1.47, so STO:XVIVO's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | +10.14% |
| 50-Day Moving Average | 232.57 |
| 200-Day Moving Average | 243.89 |
| Relative Strength Index (RSI) | 36.33 |
| Average Volume (20 Days) | 90,552 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:XVIVO had revenue of SEK 958.65 million and earned 128.85 million in profits. Earnings per share was 4.09.
| Revenue | 958.65M |
| Gross Profit | 682.30M |
| Operating Income | 127.76M |
| Pretax Income | 155.60M |
| Net Income | 128.85M |
| EBITDA | 178.94M |
| EBIT | 127.76M |
| Earnings Per Share (EPS) | 4.09 |
Balance Sheet
The company has 313.24 million in cash and 120.61 million in debt, with a net cash position of 192.63 million or 6.12 per share.
| Cash & Cash Equivalents | 313.24M |
| Total Debt | 120.61M |
| Net Cash | 192.63M |
| Net Cash Per Share | 6.12 |
| Equity (Book Value) | 2.27B |
| Book Value Per Share | 71.93 |
| Working Capital | 542.20M |
Cash Flow
In the last 12 months, operating cash flow was 268.77 million and capital expenditures -93.72 million, giving a free cash flow of 175.05 million.
| Operating Cash Flow | 268.77M |
| Capital Expenditures | -93.72M |
| Depreciation & Amortization | 51.18M |
| Net Borrowing | 72.25M |
| Free Cash Flow | 175.05M |
| FCF Per Share | 5.56 |
Margins
Gross margin is 71.17%, with operating and profit margins of 13.33% and 13.44%.
| Gross Margin | 71.17% |
| Operating Margin | 13.33% |
| Pretax Margin | 16.23% |
| Profit Margin | 13.44% |
| EBITDA Margin | 18.67% |
| EBIT Margin | 13.33% |
| FCF Margin | 18.26% |
Dividends & Yields
STO:XVIVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.06% |
| Earnings Yield | 2.05% |
| FCF Yield | 2.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for STO:XVIVO is 304.00, which is 52.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 304.00 |
| Price Target Difference | 52.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 24.92% |
| EPS Growth Forecast (3Y) | 115.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:XVIVO has an Altman Z-Score of 14.34 and a Piotroski F-Score of 6.
| Altman Z-Score | 14.34 |
| Piotroski F-Score | 6 |